Department of Biochemistry and Cytochemistry
Institute of Molecular Physiology and Genetics
sk
Menu
Home
Activities
Mission
Awards
They said about us …
Outreach
PhD Alumni
Laboratories
Cell Cultivation
Biochemistry
Electron Microscopy
Molecular Biology
Imaging Techniques
People
Researchers
Technicians
Students
Publications
Recent Publications
Profile Publications
Projects
Active projects
Completed projects
Profile Publications
>
Šereš M, Cholujová D, Bubenčíkova T, Breier A, Sulová Z.
Tunicamycin depresses p-glycoprotein glycosylation without an effect on its membrane localization and drug efflux activity in l1210 cells.
Int J Mol Sci. 12 (2011) 7772-7784. (IF
2012
=2.464)
Sulová Z, Mislovicová D, Gibalová L, Vajcnerová Z, Poláková E, Uhrík B, Tylková L, Kovarova A, Sedlák J, Breier A.
Vincristine-induced overexpression of P-glycoprotein in L1210 cells is associated with remodeling of cell surface saccharides.
J Proteome Res. 2009, 8, 513-20. (IF
2012
=5.056)
Sulová Z, Macejová D, Sereš M, Sedlák J, Brtko J, Breier A.
Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Toxicol in Vitro. 2008 22, 96-105 (IF
2012
=2.650)
Barancik M, Bohacova V, Sedlak J, Sulova Z, Breier A:
LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glykoprotein-mediated multisrug resistance.
Eur. J. Pharm. Sci. 29 (2006) 426-434 (IF
2012
=2.987)
Breier A, Barancik M, Sulova Z, Uhrik B.
P-glycoprotein–implications of metabolism of neoplastic cells and cancer therapy.
Curr Cancer Drug Targets. 5, (2005), 457-68. (IF
2012
=4.000)
Fiala R, Sulova Z, El-Saggan AH, Uhrik B, Liptaj T, Dovinova I, Hanusovska E, Drobna Z, Barancik M, Breier A:
P-glycoprotein-mediated multidrug resistance phenotype of L1210/VCR cells is associated with decreases of oligo- and/or polysaccharide contents.
Biochim Biophys Acta. 1639, (2003), 213-224. (IF
2012
=4.910)
Barancik M, Bohacova V, Kvackajova J, Hudecova S, Krizanova O, Breier A:
SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance.
Eur. J. Pharm. Sci. 14, (2001), 29-36 (IF
2012
=2.987)
Publications
Recent Publications
Profile Publications